Iberdomide, combined with Darzalex and dexamethasone, improves MRD negativity in relapsed multiple myeloma, showcasing CELMoDs' potential in treatment. Early-stage blood cancer diagnosis and ...
Significant progress in multiple myeloma treatment with bispecific antibodies shows promise for improved survival and response rates. Emphasis on accessible, low-toxicity treatments, including oral ...
September marks Blood Cancer Awareness Month, and to honour the occasion, the Leukemia & Lymphoma Society has debuted its new identity. Rebranding to Blood Cancer United, the organisation ...
Blood cancer treatment is entering a new era, bringing powerful breakthroughs that offer renewed hope to people living with leukemia, lymphoma, myeloma, and other blood cancers. Cutting-edge targeted ...
What these buzzy new tests can and can't tell you.
Study Finds on MSN
Blood Test Accurately Detects 81% Of Earliest Lung Cancers By Looking For Molecular Chaos
In A Nutshell Johns Hopkins researchers developed a blood test that catches 81% of stage IA lung cancers (the earliest, most ...
Blood cancer patients will no longer be able to receive a life-extending treatment after the NHS watchdog scrapped its use.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results